Format

Send to

Choose Destination
Am J Physiol Gastrointest Liver Physiol. 2018 Aug 1;315(2):G249-G258. doi: 10.1152/ajpgi.00039.2018. Epub 2018 Apr 6.

Cytosolic phosphoenolpyruvate carboxykinase as a cataplerotic pathway in the small intestine.

Author information

1
Advanced Imaging Research Center, The University of Texas Southwestern Medical Center , Dallas, Texas.
2
Center for Human Nutrition, The University of Texas Southwestern Medical Center , Dallas, Texas.
3
Department of Clinical Nutrition, The University of Texas Southwestern Medical Center , Dallas, Texas.
4
Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine , Nashville, Tennessee.
5
Department of Pharmacology, The University of Texas Southwestern Medical Center , Dallas, Texas.

Abstract

Cytosolic phosphoenolpyruvate carboxykinase (PEPCK) is a gluconeogenic enzyme that is highly expressed in the liver and kidney but is also expressed at lower levels in a variety of other tissues where it may play adjunct roles in fatty acid esterification, amino acid metabolism, and/or TCA cycle function. PEPCK is expressed in the enterocytes of the small intestine, but it is unclear whether it supports a gluconeogenic rate sufficient to affect glucose homeostasis. To examine potential roles of intestinal PEPCK, we generated an intestinal PEPCK knockout mouse. Deletion of intestinal PEPCK ablated ex vivo gluconeogenesis but did not significantly affect glycemia in chow, high-fat diet, or streptozotocin-treated mice. In contrast, postprandial triglyceride secretion from the intestine was attenuated in vivo, consistent with a role in fatty acid esterification. Intestinal amino acid profiles and 13C tracer appearance into these pools were significantly altered, indicating abnormal amino acid trafficking through the enterocyte. The data suggest that the predominant role of PEPCK in the small intestine of mice is not gluconeogenesis but rather to support nutrient processing, particularly with regard to lipids and amino acids. NEW & NOTEWORTHY The small intestine expresses gluconeogenic enzymes for unknown reasons. In addition to glucose synthesis, the nascent steps of this pathway can be used to support amino acid and lipid metabolisms. When phosphoenolpyruvate carboxykinase, an essential gluconeogenic enzyme, is knocked out of the small intestine of mice, glycemia is unaffected, but mice inefficiently absorb dietary lipid, have abnormal amino acid profiles, and inefficiently catabolize glutamine. Therefore, the initial steps of intestinal gluconeogenesis are used for processing dietary triglycerides and metabolizing amino acids but are not essential for maintaining blood glucose levels.

KEYWORDS:

amino acids; cataplerosis; gluconeogenesis; glyceroneogenesis; small intestine

PMID:
29631378
PMCID:
PMC6139646
[Available on 2019-08-01]
DOI:
10.1152/ajpgi.00039.2018

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center